November 27, 2015
font size

Bone Cancer Overview (cont.)

Medical Author:
Medical Editor:

What specialists treat bone cancer?

Bone cancer is typically managed by surgical oncologists or orthopedic oncologists (for surgical removal of the tumor) and medical oncologists (for administration or chemotherapy). Radiation oncologists are involved in the treatment team if radiation therapy is planned. Palliative care physicians may be involved to manage pain and symptoms.

Are there any treatments or medications that relieve bone cancer pain?

Analgesics (pain-relieving medications) treat the pain of bone cancer. These may be nonprescription or prescription medications. Mild-to-moderate pain is treated with medications such as acetaminophen (Tylenol) or nonsteroidal anti-inflammatory medications (NSAIDs), including ibuprofen (Advil, Motrin) and naproxen (Naprelan, Aleve, Naprosyn, Anaprox). However, people taking anticancer chemotherapy drugs sometimes must avoid NSAIDs because of increased risk of bleeding.

Prescription medications are used for moderate-to-severe cancer pain. Opioids -- stronger narcotic pain medications -- like codeine, morphine, oxycodone, hydromorphone, and fentanyl may be required to control severe pain. Sometimes a combination of medications is used to treat cancer pain. Opioid medications can be associated with side effects like drowsiness, constipation, and nausea.

What is the prognosis for bone cancer? What is the five-year survival rate for bone cancer?

The prognosis, or outlook, for survival for bone cancer patients depends upon the particular type of cancer and the extent to which it has spread. The overall five-year survival rate for all bone cancers in adults and children is about 70%. Chondrosarcomas in adults have an overall five-year survival rate of about 80%.

The five-year survival rate specifically for localized osteosarcomas is about 60%-80%. If the cancer has spread beyond bone, the survival rate is about 15%-30%. Osteosarcomas tend to have a more favorable prognosis if they are located in an arm or leg, respond well to chemotherapy, and are generally completely removed at surgery. Younger patients and females also tend to have a more favorable prognosis than males or older patients.

Ewing sarcomas have a five-year survival rate of about 70% when they are found in a localized stage. If they have spread outside of the bone, the survival rate drops to 15%-30%. Factors that are associated with a more favorable prognosis for Ewing sarcomas include smaller tumor size, age less than 10 years, having the cancer in an arm or leg (instead of in the pelvis or chest wall), and having a good response to chemotherapy drugs.

Medically Reviewed by a Doctor on 11/12/2015



Get the latest treatment options.

Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations